StockTipsArenaBeta

BUY Biocon Ltd — Vikas Salunkhe, Nirmal Bang Securities

BUYBiocon Ltd
Biocon share price target & all analyst calls

byVikas Salunkhe, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))27 Aug 2026via Zee Business (Live)

Entry₹417.55Inferred
Target₹440
Total upside +5.38% (call closed)
Stop loss₹408-2.29% risk
Exit₹40831 Aug 2026, 9:25 am
Stop-loss hit-2.29%
Follow Vikas Salunkhe for new calls(27% target hit, 126 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 148 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 31 Aug 2026
5 supporting2 neutral0 opposing
Supports the BUY call (5)

Biocon Biologics Secures Japan Approval for Pegfilgrastim Biosimilar

NewsGoogle News·25 Aug · 5d ago

(opens in new tab)

Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilar

NewsGoogle News·25 Aug · 5d ago

(opens in new tab)

Vikas Khemani bets big on India's manufacturing shift, sees Biocon at an "inflection point"

NewsCnbc-Tv18·21 Aug · 1w ago

(opens in new tab)

Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector

NewsEt-Markets·18 Aug · 2w ago

(opens in new tab)

5 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·17 Aug · 2w ago

Neutral / worth noting (2)

Buy, Sell Or Hold: Mahindra & Mahindra, Coforge, TVS Motor, Biocon And Divi's Labs — Ask Profit

NewsNdtv-Profit·30 Aug · today

(opens in new tab)

Buy, Sell Or Hold: Mazagon Dock, HAL, Biocon, Suzlon And Tata Motors PV — Ask Profit

NewsNdtv-Profit·18 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Vikas Salunkhe, Nirmal Bang Securities

Every call and its outcome